Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jonas A. DeSouza"'
Autor:
Naifa L. Busaidy, Bhavana Konda, Lai Wei, Lori J. Wirth, Catherine Devine, Gregory A. Daniels, Jonas A. DeSouza, Ming Poi, Nathan D. Seligson, Maria E. Cabanillas, Jennifer A. Sipos, Matthew D. Ringel, Ann-Kathrin Eisfeld, Cynthia Timmers, Manisha H. Shah
Publikováno v:
Thyroid : official journal of the American Thyroid Association. 32(10)
lt;bgt;lt;igt;Background:lt;/igt;lt;/bgt; Oncogenic BRAF mutations are commonly found in advanced differentiated thyroid cancer (DTC), and reports have shown efficacy of BRAF inhibitors in these tumors. We investigated the difference in response betw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c23df625f9d2460f3b04a8b48c5304a1
https://pubmed.ncbi.nlm.nih.gov/35658604
https://pubmed.ncbi.nlm.nih.gov/35658604
Autor:
Naifa L. Busaidy, Bhavana Konda, Lai Wei, Lori J. Wirth, Catherine Devine, Gregory A. Daniels, Jonas A. DeSouza, Ming Poi, Nathan D. Seligson, Maria E. Cabanillas, Jennifer A. Sipos, Matthew D. Ringel, Ann-Kathrin Eisfeld, Cynthia Timmers, Manisha H. Shah
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed8ec376f4a2df14e8813ab2e8991dd1
https://doi.org/10.2139/ssrn.4039920
https://doi.org/10.2139/ssrn.4039920
Autor:
Jonas A. DeSouza, Vassiliki Saloura, Allison Dekker, Everett E. Vokes, Ryan J. Brisson, Tanguy Y. Seiwert, Sara Kochanny, Saba Arshad
Publikováno v:
Head Neck
Background This study assessed the maximum tolerated dose (MTD) of the PI3K inhibitor buparlisib given concurrently with cetuximab in recurrent and metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). Methods Twelve patients with R/M HNSCC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46628d54bf097a9333f109f5a4592f8c
https://doi.org/10.1002/hed.25910
https://doi.org/10.1002/hed.25910
Autor:
Erlene K. Seymour, Jonas A. DeSouza
Publikováno v:
Blood. 128:3556-3556
Background: The ASCO Value Framework was developed to assist in value assessments (efficacy, toxicity, and cost of therapies) of drugs in cancer care. However, data on its feasibility and clinical application have not been widely reported. Given the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d47b6acc29325125e061288508d163c8
https://doi.org/10.1182/blood.v128.22.3556.3556
https://doi.org/10.1182/blood.v128.22.3556.3556
Autor:
Johannes Brägelmann, Michaela K. Keck, Arun Khattri, Everett E. Vokes, Daniel J. Haraf, Tanguy Y. Seiwert, Jonas A. DeSouza, Mark W. Lingen, Victoria M. Villaflor, Zhixiang Zuo
Publikováno v:
ResearcherID
6080 Background: Whileeffects of specific genetic aberrations on outcome in HNC have been described (Poeta 2007, Gross 2014), the impact of therapies in genetic subgroups remains unknown. We theref...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a77d7d3e153904ef58e6dbacffbef071
https://doi.org/10.1200/jco.2015.33.15_suppl.6080
https://doi.org/10.1200/jco.2015.33.15_suppl.6080
Autor:
Zhixiang Zuo, Jonas A. DeSouza, Victoria M. Villaflor, Michaela K. Keck, Paul Geeleher, Arun Khattri, Jana Heitmann, Everett E. Vokes, Mark W. Lingen, Tanguy Y. Seiwert, Michael A. Beckett, Ralph R. Weichselbaum
Publikováno v:
ResearcherID
6094 Background: Cancers deficient in homologous recombination (HR) exhibit synthetic lethality when treated with poly (ADP-ribose) polymerase (PARP) inhibitors and may be more sensitive to platinu...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e9460b39c4a1dd90b626a8a927252aa
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000358613203684&KeyUID=WOS:000358613203684
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000358613203684&KeyUID=WOS:000358613203684
